美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NETLease Corporate Real Estate ETF

23.98

+0.73663.17%

盤後：23.980.00000.00%19:30 EDT

成交量：8,695

成交額：20.74萬

市值：4,675.92萬

市盈率：- -

高：23.98

開：23.80

低：23.68

收：23.24

52周最高：28.43

52周最低：23.24

股本：195.00萬

流通股本：195.00萬

量比：0.48

換手率：0.45%

股息：1.26

股息率：5.25%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

優赫得®在中國獲批用於既往接受過治療的HER2陽性轉移性實體瘤患者，成為中國首個且唯一*獲批泛腫瘤適應症的靶向HER2抗體偶聯藥物

不限癌種！優赫得泛腫瘤適應症在華獲批

南方财经网

蛋白粉價格持續走高「蟑螂粉」當平替，你敢吃嗎？

艾格里房產第三季度核心運營現金流每股1.15美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/NETL"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NETL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NETL\",,,,,undefined,":{"symbol":"NETL","market":"US","secType":"STK","nameCN":"NETLease Corporate Real Estate ETF","latestPrice":23.9791,"timestamp":1792699200000,"preClose":23.2425,"halted":0,"volume":8695,"hourTrading":{"tag":"盘后","latestPrice":23.9791,"preClose":23.9791,"latestTime":"19:30 EDT","volume":7,"amount":167.8537,"timestamp":1792711801684,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03169194363773257,"floatShares":1950000,"shares":1950000,"eps":0,"marketStatus":"已收盤","change":0.7366,"latestTime":"10-22 16:00:00 EDT","open":23.795,"high":23.9791,"low":23.6804,"amount":207396.00934999998,"amplitude":0.012851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1792742400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":23.2425,"sharesOutstanding":1775000,"nav":23.29,"aum":45415500,"dividendRate":0.052546,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.9791,"preClose":23.9791,"latestTime":"19:30 EDT","volume":7,"amount":167.8537,"timestamp":1792711801684,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.482284,"impliedVol":0.0189,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NETL\",,,,,undefined,":{"symbol":"NETL","floatShares":1950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.482284,"shares":1950000,"dividePrice":1.26,"high":23.9791,"amplitude":0.012851,"preClose":23.2425,"low":23.6804,"week52Low":23.2425,"pbRate":"--","week52High":28.4299,"institutionHeld":0,"latestPrice":23.9791,"eps":0,"divideRate":0.052546,"volume":8695,"delay":0,"ttmEps":0,"open":23.795,"prevYearClose":23.727,"prevWeekClose":23.918,"prevMonthClose":23.89,"prevQuarterClose":23.89,"fiveDayClose":23.8467,"twentyDayClose":24.38,"sixtyDayClose":27.6672},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NETL\",params:#limit:5,,,undefined,":[{"date":"2026-09-28","symbol":"NETL","amount":0.105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-28","defaultRemindTime":1790602200000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-30","payableDate":"2026-09-28","currency":"USD","dateTimestamp":1790568000000,"payDate":"2026-09-30"},{"date":"2026-08-27","symbol":"NETL","amount":0.105,"announcedDate":"2026-08-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-27","defaultRemindTime":1787837400000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-31","payableDate":"2026-08-27","currency":"USD","dateTimestamp":1787803200000,"payDate":"2026-08-31"},{"date":"2026-07-29","symbol":"NETL","amount":0.105,"announcedDate":"2026-07-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-29","defaultRemindTime":1785331800000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-31","payableDate":"2026-07-29","currency":"USD","dateTimestamp":1785297600000,"payDate":"2026-07-31"},{"date":"2026-06-26","symbol":"NETL","amount":0.105,"announcedDate":"2026-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-26","defaultRemindTime":1782480600000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-26","currency":"USD","dateTimestamp":1782446400000,"payDate":"2026-06-30"},{"date":"2026-05-27","symbol":"NETL","amount":0.105,"announcedDate":"2026-05-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-27","defaultRemindTime":1779888600000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-27","currency":"USD","dateTimestamp":1779854400000,"payDate":"2026-05-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NETL\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-30","recordDate":"2019-12-31","paymentDate":"2020-01-02","value":0.031935,"currency":"USD"},{"executeDate":"2020-03-17","recordDate":"2020-03-18","paymentDate":"2020-03-19","value":0.0097783,"currency":"USD"},{"executeDate":"2020-03-31","recordDate":"2020-04-01","paymentDate":"2020-04-02","value":0.1912399,"currency":"USD"},{"executeDate":"2020-06-26","recordDate":"2020-06-29","paymentDate":"2020-06-30","value":0.2782635,"currency":"USD"},{"executeDate":"2020-09-15","recordDate":"2020-09-16","paymentDate":"2020-09-30","value":0.2792338,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NETL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NETL\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2677680389","title":"優赫得®在中國獲批用於既往接受過治療的HER2陽性轉移性實體瘤患者，成為中國首個且唯一*獲批泛腫瘤適應症的靶向HER2抗體偶聯藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2677680389","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677680389?lang=zh_tw&edition=fundamental","pubTime":"2026-10-22 19:20","pubTimestamp":1792668000,"startTime":"0","endTime":"0","summary":"过去，HER2靶向治疗主要针对特定瘤种。此次德曲妥珠单抗作为靶向HER2的泛肿瘤治疗方案获批，并在多种HER2阳性实体瘤中展现出具有临床意义的疗效应答，为这部分既往治疗选择有限的患者带来了新的希望。此次获批标志着德曲妥珠单抗已在中国获批十项适应症，也是其不到一年内在中国获批的第六项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5078812_ZH78812_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5078812_ZH78812_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ADC","BK4080","IBBQ","LU0109394709.USD","BK4568","LU2237443382.USD","LU2462157665.USD","NETL","BK4585","LU2417539215.USD","LU0029864427.USD","AZNH","BK4213","LU0128525929.USD","LU0708994859.HKD","BK4007","LU0889565916.HKD","LU2089984988.USD","LU0058720904.USD","LU2237443549.SGD","BK4195","LU0320765992.SGD","FXN","IE00B3T34201.USD","PXI","PFS","LU1829250122.USD","LU2237443465.HKD","LU0289739699.SGD","LU2456880835.USD","LU2237443895.HKD","LU0310800379.SGD","AZN","PR","CR","LU0432979614.USD","LU1267930573.SGD","LU2468319806.SGD","LU2237443622.USD","BK4161","BK4231","LU2236285917.USD","BK4588","ORR","BK4211","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677932937","title":"不限癌種！優赫得泛腫瘤適應症在華獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2677932937","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677932937?lang=zh_tw&edition=fundamental","pubTime":"2026-10-22 15:41","pubTimestamp":1792654860,"startTime":"0","endTime":"0","summary":"南方财经10月22日电，阿斯利康今日宣布，由阿斯利康和第一三共共同开发与商业化的优赫得?（英文商品名：Enhertu?，通用名：注射用德曲妥珠单抗）于2026年10月20日正式获得中国国家药品监督管理局（NMPA）批准，单药适用于治疗既往接受过治疗或无满意替代治疗方案的不可切除或转移性HER2表达为IHC3+的成人实体瘤患者。该适应症是基于单臂临床试验的结果给予的附条件批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610223904083542.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610223904083542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4231","BK4080","ADC","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677603079","title":"蛋白粉價格持續走高 「蟑螂粉」當平替，你敢吃嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2677603079","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677603079?lang=zh_tw&edition=fundamental","pubTime":"2026-10-22 00:09","pubTimestamp":1792598940,"startTime":"0","endTime":"0","summary":"■不少蟑螂粉产品带“增急字眼。网络截图■有网友表示对蟑螂粉好奇。网络截图■博主测评蟑螂粉。网络截图专家：小心重金属超标、微生物超标、致敏等风险近两年，蛋白粉价格持续走高，不少健 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261022/c680948812.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261022/c680948812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU0757428866.USD","WPC","INDS","NETL","SNEX","LU1559883803.SGD","BK4160","LU0053671581.USD","BK4127","LU1815336091.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185387701","title":"艾格里房產第三季度核心運營現金流每股1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185387701","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185387701?lang=zh_tw&edition=fundamental","pubTime":"2026-10-21 04:19","pubTimestamp":1792527576,"startTime":"0","endTime":"0","summary":"艾格里房产公布，第三季度净利润达到6854.3万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","ADC","BK4080","NETL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":21,"pageCount":1,"totalSize":82,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NETL\",params:#limit:6,delay:false,,,undefined,":[]}}